To prevent Meditech from qualifying a patient for EXM when mixed-field agglutination is detected, then detection of a mixed-field result must be entered into Meditech in some manner. In this way, Meditech can react to that test result using rules, reflexing tests, calculations and interpretations.
Currently, if mixed-field agglutination is detected in the Anti-A, Anti-B, Anti-A,B and/or Anti-D test, how is that mixed-field test result entered into Meditech?
What is your current policy for documenting selection of blood for transfusion in Meditech when mixed-field agglutination is detected in ABO/Rh grouping tests? For example, do you automatically select group O when mixed-field is detected in ABO grouping? Rh negative when mixed-field is detected in Rh grouping?
How is your Crossmatch test configured?
Do you use a Meditech Blood Issue routine in real-time when releasing blood to Nursing, et al?